These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 8781355)

  • 1. Molecular events during myofibroblast activation: is there specificity?
    Trautwein C
    Hepatology; 1996 Sep; 24(3):742-4. PubMed ID: 8781355
    [No Abstract]   [Full Text] [Related]  

  • 2. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.
    Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K
    Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myb binding proteins: regulators and cohorts in transformation.
    Ness SA
    Oncogene; 1999 May; 18(19):3039-46. PubMed ID: 10378699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of fibroblast growth factor 2 expression in melanoma cells by the c-MYB proto-oncoprotein.
    Miglarese MR; Halaban R; Gibson NW
    Cell Growth Differ; 1997 Nov; 8(11):1199-210. PubMed ID: 9372243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional regulation by the carboxyl terminus of c-Myb depends upon both the Myb DNA-binding domain and the DNA recognition site.
    Dubendorff JW; Lipsick JS
    Oncogene; 1999 Jun; 18(23):3452-60. PubMed ID: 10376523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
    Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
    Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inability of transforming growth factor-beta to cause SnoN degradation leads to resistance to transforming growth factor-beta-induced growth arrest in esophageal cancer cells.
    Edmiston JS; Yeudall WA; Chung TD; Lebman DA
    Cancer Res; 2005 Jun; 65(11):4782-8. PubMed ID: 15930298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of an artificial tandem protein of the c-Myb DNA-binding domain and analysis of its DNA binding specificity.
    Oda M; Furukawa K; Sarai A; Nakamura H
    Biochem Biophys Res Commun; 1999 Aug; 262(1):94-7. PubMed ID: 10448074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGF-binding proteins mediate TGF-beta 1-induced apoptosis in bovine mammary epithelial BME-UV1 cells.
    Gajewska M; Motyl T
    Comp Biochem Physiol C Toxicol Pharmacol; 2004 Oct; 139(1-3):65-75. PubMed ID: 15556067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic expression of c-Myb in chronic human liver disease.
    Kitada T; Seki S; Nakatani K; Kawada N; Kuroki T; Monna T
    Hepatology; 1997 Dec; 26(6):1506-12. PubMed ID: 9397991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta receptor expression and smad2 localization are cell density dependent in fibroblasts.
    Petridou S; Maltseva O; Spanakis S; Masur SK
    Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):89-95. PubMed ID: 10634606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capillary electrophoretic mobility shift assay (CEMSA) of a protein-DNA complex.
    Xue B; Gabrielsen OS; Myrset AH
    J Capillary Electrophor; 1997; 4(5):225-31. PubMed ID: 9725121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Ski inhibits the TGF-beta signaling pathway through stabilization of inactive Smad complexes on Smad-binding elements.
    Suzuki H; Yagi K; Kondo M; Kato M; Miyazono K; Miyazawa K
    Oncogene; 2004 Jun; 23(29):5068-76. PubMed ID: 15107821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential dynamics from NMR clusters: dynamic properties of the Myb DNA-binding domain and a hinge-bending enhancing variant.
    van Aalten DM; Grotewold E; Joshua-Tor L
    Methods; 1998 Mar; 14(3):318-28. PubMed ID: 9571087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGF-I and TGF-beta1 have distinct effects on phenotype and proliferation of intestinal fibroblasts.
    Simmons JG; Pucilowska JB; Keku TO; Lund PK
    Am J Physiol Gastrointest Liver Physiol; 2002 Sep; 283(3):G809-18. PubMed ID: 12181198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smad3/AP-1 interactions control transcriptional responses to TGF-beta in a promoter-specific manner.
    Verrecchia F; Vindevoghel L; Lechleider RJ; Uitto J; Roberts AB; Mauviel A
    Oncogene; 2001 Jun; 20(26):3332-40. PubMed ID: 11423983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-MYB transactivates its own promoter through SP1-binding sites.
    Sala A; Saitta B; De Luca P; Cervellera MN; Casella I; Lewis RE; Watson R; Peschle C
    Oncogene; 1999 Feb; 18(6):1333-9. PubMed ID: 10022815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
    Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
    Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
    Lennartsson A; Garwicz D; Lindmark A; Gullberg U
    Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transactivation of the GATA-1 promoter by a myb-ets-containing mouse retrovirus is mediated by CACCC elements.
    Sun-Hoffman L; Aurigemma RE; Sun B; Ruscetti SK
    Oncogene; 1996 Sep; 13(5):1037-42. PubMed ID: 8806693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.